Elacestrant hydrochloride
- Generic Name
- Elacestrant hydrochloride
Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms
- First Posted Date
- 2016-01-12
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Radius Pharmaceuticals, Inc.
- Target Recruit Count
- 139
- Registration Number
- NCT02653417
- Locations
- 🇺🇸
Women's Health Care Specialists P.C. - Beyer Research, Kalamazoo, Michigan, United States
Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer
- First Posted Date
- 2016-01-08
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Stemline Therapeutics, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT02650817
- Locations
- 🇧🇪
UZ Leuven Campus Gasthuisberg, Leuven, Belgium
🇳🇱Erasmus Medical Center, Rotterdam, Netherlands
🇧🇪Institut Jules Bordet, Bruxelles, Belgium
A Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women
- First Posted Date
- 2009-04-03
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- Radius Pharmaceuticals, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT00875420
- Locations
- 🇺🇸
Radius Health, Inc., Cambridge, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath